China’s insulin plans will hit 2022 revenues, says Novo NordiskNovo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government Share XChina’s insulin plans will hit 2022 revenues, says Novo Nordiskhttps://pharmaphorum.com/news/chinas-insulin-plans-will-hit-2022-revenues-says-novo-nordisk/
Turkey’s home-grown COVID vaccine project nears fruitionTurkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according Share XTurkey’s home-grown COVID vaccine project nears fruitionhttps://pharmaphorum.com/news/turkeys-home-grown-covid-vaccine-project-nears-fruition/
Could safety scupper Ionis, Pfizer’s cholesterol drug vupanorsen?Ionis has reported phase 2b trial data for its Pfizer-partnered antisense drug vupanorsen for cholesterol lowering that showed Share XCould safety scupper Ionis, Pfizer’s cholesterol drug vupanorsen?https://pharmaphorum.com/news/could-safety-scupper-ionis-pfizers-cholesterol-drug-vupanorsen/
UK digital health firm Ieso raises $53m for US expansionIeso has raised $53 million in second-round financing that will be used to bring its digital therapeutics (DTx) Share XUK digital health firm Ieso raises $53m for US expansionhttps://pharmaphorum.com/news/uk-digital-health-firm-ieso-raises-53m-for-us-expansion/
EU authorises first COVID-19 vaccine for 5 to 11 year oldsThe European Medicines Agency (EMA) has approved Pfizer and BioNTech’s COVID-19 vaccine Comirnaty for children between the ages Share XEU authorises first COVID-19 vaccine for 5 to 11 year oldshttps://pharmaphorum.com/news/eu-approves-first-covid-19-vaccine-for-5-to-11-year-olds/
New COVID variant ‘may sidestep vaccine protection’A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears Share XNew COVID variant ‘may sidestep vaccine protection’https://pharmaphorum.com/news/new-covid-variant-may-sidestep-vaccine-protection/
Trial of intranasal Alzheimer’s vaccine gets underway in USThe first patients are now being treated as part of a first-in-human trial of a vaccine, administered as Share XTrial of intranasal Alzheimer’s vaccine gets underway in UShttps://pharmaphorum.com/news/trial-of-intranasal-alzheimers-vaccine-gets-underway-in-us/
After Scotland says no, NICE backs Lilly’s Retsevmo for lung cancerEli Lilly’s RET inhibitor Retsevmo can now be prescribed on the NHS for people with RET fusion-positive advanced Share XAfter Scotland says no, NICE backs Lilly’s Retsevmo for lung cancerhttps://pharmaphorum.com/news/after-scotland-says-no-nice-backs-lillys-retsevmo-for-lung-cancer/
Kura hit as FDA slaps partial hold on leukaemia trialShare in Kura Oncology have come under pressure after a patient death in a clinical trial of the Share XKura hit as FDA slaps partial hold on leukaemia trialhttps://pharmaphorum.com/news/kura-hit-as-fda-slaps-partial-hold-on-leukaemia-trial/
